论文部分内容阅读
众所周知,慢性充血性心力衰竭(CHF)是各种心脏病的最终结局,5年存活率与恶性肿瘤接近,是一组复杂的临床症状群,也是最主要的死亡原因。血管紧张素转换酶抑制剂(ACEI)已被列为治疗CHF的一线药物,关于ACEI治疗CHF的最佳剂量,临床研究尚少,我们选用较大剂量的依那普利治疗CHF108例,报告如下。1资料与方法
As we all know, chronic congestive heart failure (CHF) is the ultimate outcome of all kinds of heart disease, 5-year survival rate close to malignant tumors, is a complex group of clinical symptoms, but also the leading cause of death. Angiotensin converting enzyme inhibitor (ACEI) has been listed as the first-line treatment of CHF drugs, the optimal dose of ACEI for the treatment of CHF, clinical research is still small, we choose larger doses of enalapril treatment of CHF108 cases, the report is as follows . 1 data and methods